Ciska Verbaanderd
Impact in
- Physiology top 10%
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 5
- Pharmaceutical Economics and Policy 4
-
- Biomedical Ethics and Regulation 5
- Co-authors
- Pan Pantziarka (4 shared papers)Isabelle Huys (6 shared papers)Lydie Meheus (4 shared papers)Gauthier Bouche (3 shared papers)Vikas P. Sukhatme (2 shared papers)Vidula Sukhatme (2 shared papers)Ilse Rooman (3 shared papers)Patrizia Agostinis (1 shared paper)
- Journals
- Frontiers in Medicine (2 papers)Frontiers in Pharmacology (2 papers)ESMO Open (1 paper)Seminars in Cancer Biology (1 paper)Trials (1 paper)
- Partner nations
- BelgiumUnited KingdomUnited States
In The Last Decade
Ciska Verbaanderd
12 papers receiving 544 citations
Peers
Comparison fields: 5 of 83
- Physiology 27
- Cancer Research 64
- Computational Theory and Mathematics 69
- Oncology 92
- Pharmacology 30
Countries citing papers authored by Ciska Verbaanderd
This map shows the geographic impact of Ciska Verbaanderd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciska Verbaanderd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciska Verbaanderd more than expected).
Fields of papers citing papers by Ciska Verbaanderd
This network shows the impact of papers produced by Ciska Verbaanderd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciska Verbaanderd. The network helps show where Ciska Verbaanderd may publish in the future.
Co-authors
The 25 scholars most cited alongside Ciska Verbaanderd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 207 | |
| 2 | 2018 | 103 | |
| 3 | 2017 | 64 | |
| 4 | 2020 | 53 | |
| 5 | 2020 | 43 | |
| 6 | 2021 | 23 | |
| 7 | 2015 | 22 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 9 | |
| 10 | 2023 | 8 | |
| 11 | 2020 | 8 | |
| 12 | 2021 | 3 |
About Ciska Verbaanderd
Ciska Verbaanderd is a scholar working on Economics and Econometrics, Physiology, Pediatrics, Perinatology and Child Health, Molecular Biology and General Health Professions, having authored 12 papers that have together received 552 indexed citations. Recurring topics across this work include Biomedical Ethics and Regulation (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Pharmaceutical Economics and Policy (4 papers), Pharmaceutical studies and practices (3 papers), Pharmacogenetics and Drug Metabolism (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Cancer Genomics and Diagnostics (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Physiology (27 citations), Cancer Research (64 citations), Computational Theory and Mathematics (69 citations), Oncology (92 citations) and Pharmacology (30 citations). Ciska Verbaanderd has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Pan Pantziarka, Isabelle Huys, Lydie Meheus, Gauthier Bouche, Vikas P. Sukhatme, Vidula Sukhatme, Ilse Rooman, Patrizia Agostinis, Hannelore Maes and Marco B.E. Schaaf. Their work appears in journals such as Frontiers in Medicine, Frontiers in Pharmacology, ESMO Open, Seminars in Cancer Biology and Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.